BIASCO, ELISA
 Distribuzione geografica
Continente #
NA - Nord America 524
EU - Europa 193
AS - Asia 72
AF - Africa 19
OC - Oceania 2
Totale 810
Nazione #
US - Stati Uniti d'America 513
SE - Svezia 50
IT - Italia 48
CN - Cina 30
SG - Singapore 27
BG - Bulgaria 26
DE - Germania 25
GB - Regno Unito 24
VN - Vietnam 12
CA - Canada 11
CI - Costa d'Avorio 11
FI - Finlandia 8
SN - Senegal 8
CH - Svizzera 5
AU - Australia 2
FR - Francia 2
HK - Hong Kong 2
UA - Ucraina 2
IN - India 1
NL - Olanda 1
NO - Norvegia 1
RU - Federazione Russa 1
Totale 810
Città #
Houston 77
Fairfield 72
Woodbridge 53
Chandler 39
Ann Arbor 38
Sofia 26
Ashburn 24
Seattle 23
New York 20
Cambridge 18
Wilmington 16
Dearborn 15
Princeton 14
Serra 13
Abidjan 11
Frankfurt am Main 10
Lawrence 10
Ottawa 10
Beijing 9
Lancaster 9
Pisa 9
Dakar 8
Medford 8
Des Moines 7
Florence 7
Nanjing 7
Dong Ket 6
Los Angeles 6
London 5
San Diego 5
Singapore 5
Grafing 4
Hefei 4
Blackburn 3
Boulder 3
Besencens 2
Bremen 2
Changsha 2
Düsseldorf 2
Hong Kong 2
La Spezia 2
Phoenix 2
Canberra 1
Caserta 1
Geneva 1
Guangzhou 1
Hebei 1
Hounslow 1
Jüchen 1
Kilburn 1
Kunming 1
Lappeenranta 1
Markham 1
Massa 1
Milan 1
Nanchang 1
Netherby 1
Ogden 1
Oslo 1
Positano 1
Redwood City 1
San Francisco 1
Shenyang 1
Utrecht 1
Viareggio 1
Washington 1
Totale 632
Nome #
Feasibility and efficacy of 223Ra-dichloride (223Ra) to treat bone metastases in patients (pts) with castration resistant prostate cancer (mCRPC) 118
Impact of a supportive care service for cancer outpatients: management and reduction of hospitalizations. Preliminary results of an integrated model of care 109
Small-bowel neuroendocrine tumor and retroperitoneal fibrosis: Efficacy of octreotide and tamoxifen 104
The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer Patients 100
New Prognostic factors for second-line targeted therapy (TT) in metastatic renal cell carcinoma (mRCC). 88
Pharmacogenetics of androgen signaling in prostate cancer: focus on castration resistance and predictive biomarkers of response to treatment 87
predictive factors of efficacy of somatostatine analogs (SSA) in gastroenteropancreatic neuroendocrine tumors (GEP-NET) 76
Reply to Ugo De Giorgi, Vincenza Conteduca, and Emanuela Scarpi's Letter to the Editor re: Marzia Del Re, Elisa Biasco, Stefania Crucitta, et al. The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer Patients. Eur Urol 2017;71:680–7 55
metastatic well or moderately differentiated Neuroendocrine tumors (WDNET) treated with sequence of different Somatostatin Analogs (SSA) - Lanreotide LAR (La), Octreotide LAR (Oc): a single center experience 54
EARLY AND COMPLETE CLINICAL RESPONSE TO SUNITINIB IN A PATIENT WITH METASTATIC RENAL CANCER 42
Totale 833
Categoria #
all - tutte 2.495
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.495


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020155 21 7 16 13 15 29 17 10 17 4 5 1
2020/202153 4 1 3 2 4 1 0 3 9 8 2 16
2021/202295 0 5 4 1 19 17 3 2 2 3 5 34
2022/2023153 14 31 17 2 8 17 0 5 43 2 14 0
2023/202490 2 6 18 2 9 23 10 1 1 6 2 10
Totale 833